Oakworth Capital’s iShares Biotechnology ETF IBB Stock Holding History

Oakworth Capital’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$635K	Hold	3,018	–	–	0.03%	133
2026 Q2	$574K	Buy	3,018 +5	+0.2%	+$859	0.03%	140
2026 Q1	$509K	Hold	3,013	–	–	0.03%	140
2025 Q4	$509K	Hold	3,013	–	–	0.03%	133
2025 Q3	$435K	Buy	3,013 +13	+0.4%	+$1.77K	0.03%	149
2025 Q2	$380K	Hold	3,000	–	–	0.02%	146
2025 Q1	$384K	Hold	3,000	–	–	0.03%	141
2024 Q4	$397K	Hold	3,000	–	–	0.03%	141
2024 Q3	$437K	Hold	3,000	–	–	0.03%	129
2024 Q2	$412K	Hold	3,000	–	–	0.03%	129
2024 Q1	$412K	Hold	3,000	–	–	0.03%	132
2023 Q4	$408K	Buy	+3,000	New	+$366K	0.03%	135
2021 Q3	–	Sell	-1	Closed	–	–	582
2021 Q2	$0	Hold	1	–	–	﹤0.01%	596
2021 Q1	$0	Hold	1	–	–	﹤0.01%	589
2020 Q4	$0	Hold	1	–	–	﹤0.01%	583
2020 Q3	$0	Sell	1 -2	-67%	-$271	﹤0.01%	584
2020 Q2	$0	Sell	3 -54,009	-100%	-$6.88M	﹤0.01%	571
2020 Q1	$5.82M	Buy	54,012 +53,537	+11,271%	+$6.16M	1.37%	15
2019 Q4	$57K	Hold	475	–	–	0.01%	277
2019 Q3	$47K	Hold	475	–	–	0.01%	295
2019 Q2	$52K	Buy	475 +300	+171%	+$31.9K	0.01%	314
2019 Q1	$20K	Sell	175 -105	-38%	-$11.5K	﹤0.01%	390
2018 Q4	$27K	Hold	280	–	–	0.01%	352
2018 Q3	$34K	Hold	280	–	–	0.01%	338
2018 Q2	$31K	Hold	280	–	–	0.01%	346
2018 Q1	$29K	Buy	280 +207	+284%	+$22.9K	0.01%	327
2017 Q4	$23K	Buy	+73	New	+$7.8K	0.01%	371
2014 Q4	–	Sell	-81	Closed	-$7K	–	516
2014 Q3	$7K	Hold	81	–	–	﹤0.01%	308
2014 Q2	$7K	Hold	81	–	–	﹤0.01%	311
2014 Q1	$6K	Hold	81	–	–	﹤0.01%	316
2013 Q4	$6K	Buy	+81	New	+$5.75K	﹤0.01%	299

Other funds holding IBB

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $84.4B AUM 20.16% 1-Year Est. Return

WestEnd Advisors Charlotte, North Carolina $4.53B AUM 12.98% 1-Year Est. Return

Jefferies Financial Group New York $13.5B AUM 36.68% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $191B AUM 30.51% 1-Year Est. Return

Thrivent Financial for Lutherans Minneapolis, Minnesota $61B AUM 26.91% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $179B AUM 29.92% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $313B AUM 26.62% 1-Year Est. Return

Oakworth Capital's IBB Position: Q3 2026 in Review

Oakworth Capital held its iShares Biotechnology ETF (IBB) position steady in Q3 2026 at 3,018 shares worth $635K. The position accounts for 0.03% of the portfolio, ranked #133.

Oakworth Capital first reported a position in IBB in Q4 2013 and has held it in 31 quarters since. The position peaked at $5.82M in Q1 2020. 700 funds tracked by Wall St. Rank hold IBB as of Q3 2026.

Oakworth Capital held 3,018 shares of iShares Biotechnology ETF worth $635K as of Q3 2026.
Oakworth Capital left its iShares Biotechnology ETF share count unchanged in Q3 2026.
iShares Biotechnology ETF made up 0.03% of Oakworth Capital's portfolio in Q3 2026, its #133 holding.
Oakworth Capital first reported a position in iShares Biotechnology ETF in Q4 2013 and has held it in 31 quarters since.
Oakworth Capital's iShares Biotechnology ETF position peaked at $5.82M in Q1 2020.
700 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2026.

Based on Oakworth Capital's 13F filing for Q3 2026, filed 26 Oct 2026.